1. Kukharchik J., Gutikova L. Serotonin and products of its degradation as predictor of noncarrying pregnancy in the I trimester // ISSC. 20 International students scientific conference for students and young doctors, Gdansk, 19-21 april 2012: abstract book.- Gdansk, 2012.- P.64.
  2. Kukharchik Yu.V. , Gutikova L.V. Pharmacological correction of a spontaneous abortion at women with noncarrying of pregnancy // Archives of Perinatal Medicine. – 2012. – № 18(2). – P. 117–119.
  3. The contribution of founder mutations in BRCA1 to breast cancer in Belarus // Uglanitsa N., Оszurek O., Uglanitsa К., Savonievich E., Lubnski  J., Cybulski C., Debniak T., Narod S.A., Gronwald J. // Clinical Genetics.- 2010.-Vol.78. – Р.377-380
  4. BRCA1 founder mutations compared to ovarian cancer in Belarus // Savanevich A., Oszurek O., Lubinski J., Сybulski C., Debniak T., Narod S., Gronwald .J. // Familian Cancer.- 2014.- № 13.-  С.445-447
  1. Kukharchyk Yu.V., Dubrouscaya V.V. Indicators of an exchange of catecholamines as diagnostic criteria of thret of a spontaneous abortion in the I trimester: 9th Warsaw international medical congress for young scietist, Warsaw, 9-12 may 2013 r // Archives of Medical Science.- , 2013.- № 1.- Р.255.
  2. Kukharchyk Y. Antioxidative activity of blood at unmaturing pregnancy // ISSC. 22 International students scientific conference for students and young doctors: abstract book.- Gdansk, 2014.- Р.216.
  3. Kukharchyk Y .V. Correction of threat of interruption of pregnancy of early terms // 1st Lublin International congress for medical students and young doctors.- Lublin, 2014.- Р.20.
  4. Gutikova L.V., Paulouskaya М.А., Kukharchyk Y.V. Immunohistoghemical testing of matrix metalloproteinase-9 and cyclin D1 in hypererplastic endometrium in women of reproductive age // 11 Congress of the European Society of Gynecology Congres de la Societe Europeenne de Gynecologie: abstract.- Prague, 2015.- Р.1.
  5. Hutsikava L., Kukharchyk Y. Preoperative preparation of women with uterine myoma // 17th World Congress on Human Reproduction, Rome, 15-18 March 2017. – Rome, 2017. – P. 31.
  6. Kukharchyk Y., Hutsikava L. Expression of vascular endothelial growth factor and Ki-67 in women with uterine myoma // 13th European days of the French society of gynecology, Paris, 2-4 February 2017. – P. 46.
  7. Rapid selection of BRCA-1 proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers  // Sokolenko A.P., Savonevich E.L., Ivantsov A.O., Raskin G.A., Kuligina E.S., Gorodnova T.V., Preobrazhenskaya E.V., Kleshchov M.A., Tiurin V.I., Mukhina M.S.,  Kotiv K.B., Shulga A.V., Kuznetsov S.G., Berlev I.V., Imyanitov E.N. // Cancer Letters. – 2017.- Vol.397.- P.127-132
  8. Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance // Imyanitov E., Savonevich E., Ivantsov A., Raskin G., Kuligina E., Gorodnova T., Preobrazhenskaya E., Kleshchov M., Tiurin V., Togo A., Sokolenko A. // Annals of Oncology. – Vol. 28. Suppl. 5.- P. 582-583.
  9. Loss of heterozygosity at the BRCA1 locus as a marker of sensitivity for adjuvant chemotherapy in hereditary ovarian cancer // Savonevich E.L., Sokolenko A.P. Stepuro T.L. Shulga A.V.Berlev I.V.Imyanitov E.N. // Biological Markers in Fundamental and Clinical Medicine. – 2017.- Vol.1 №3. – Р.29-31.

 

  1. Kukharchik J., Gutikova L. Serotonin and products of its degradation as predictor of noncarrying pregnancy in the I trimester // ISSC. 20 International students scientific conference for students and young doctors, Gdansk, 19-21 april 2012: abstract book.- Gdansk, 2012.- P.64.
  2. Kukharchik Yu.V. , Gutikova L.V. Pharmacological correction of a spontaneous abortion at women with noncarrying of pregnancy // Archives of Perinatal Medicine. – 2012. – № 18(2). – P. 117–119.
  3. The contribution of founder mutations in BRCA1 to breast cancer in Belarus // Uglanitsa N., Оszurek O., Uglanitsa К., Savonievich E., Lubnski  J., Cybulski C., Debniak T., Narod S.A., Gronwald J. // Clinical Genetics.- 2010.-Vol.78. – Р.377-380
  4. BRCA1 founder mutations compared to ovarian cancer in Belarus // Savanevich A., Oszurek O., Lubinski J., Сybulski C., Debniak T., Narod S., Gronwald .J. // Familian Cancer.- 2014.- № 13.-  С.445-447
  1. Kukharchyk Yu.V., Dubrouscaya V.V. Indicators of an exchange of catecholamines as diagnostic criteria of thret of a spontaneous abortion in the I trimester: 9th Warsaw international medical congress for young scietist, Warsaw, 9-12 may 2013 r // Archives of Medical Science.- , 2013.- № 1.- Р.255.
  2. Kukharchyk Y. Antioxidative activity of blood at unmaturing pregnancy // ISSC. 22 International students scientific conference for students and young doctors: abstract book.- Gdansk, 2014.- Р.216.
  3. Kukharchyk Y .V. Correction of threat of interruption of pregnancy of early terms // 1st Lublin International congress for medical students and young doctors.- Lublin, 2014.- Р.20.
  4. Gutikova L.V., Paulouskaya М.А., Kukharchyk Y.V. Immunohistoghemical testing of matrix metalloproteinase-9 and cyclin D1 in hypererplastic endometrium in women of reproductive age // 11 Congress of the European Society of Gynecology Congres de la Societe Europeenne de Gynecologie: abstract.- Prague, 2015.- Р.1.
  5. Hutsikava L., Kukharchyk Y. Preoperative preparation of women with uterine myoma // 17th World Congress on Human Reproduction, Rome, 15-18 March 2017. – Rome, 2017. – P. 31.
  6. Kukharchyk Y., Hutsikava L. Expression of vascular endothelial growth factor and Ki-67 in women with uterine myoma // 13th European days of the French society of gynecology, Paris, 2-4 February 2017. – P. 46.
  7. Rapid selection of BRCA-1 proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers  // Sokolenko A.P., Savonevich E.L., Ivantsov A.O., Raskin G.A., Kuligina E.S., Gorodnova T.V., Preobrazhenskaya E.V., Kleshchov M.A., Tiurin V.I., Mukhina M.S.,  Kotiv K.B., Shulga A.V., Kuznetsov S.G., Berlev I.V., Imyanitov E.N. // Cancer Letters. – 2017.- Vol.397.- P.127-132
  8. Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance // Imyanitov E., Savonevich E., Ivantsov A., Raskin G., Kuligina E., Gorodnova T., Preobrazhenskaya E., Kleshchov M., Tiurin V., Togo A., Sokolenko A. // Annals of Oncology. – Vol. 28. Suppl. 5.- P. 582-583.
  9. Loss of heterozygosity at the BRCA1 locus as a marker of sensitivity for adjuvant chemotherapy in hereditary ovarian cancer // Savonevich E.L., Sokolenko A.P. Stepuro T.L. Shulga A.V.Berlev I.V.Imyanitov E.N. // Biological Markers in Fundamental and Clinical Medicine. – 2017.- Vol.1 №3. – Р.29-31.
  10.